Hyperinsulinemic hypoglycaemia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

5 events
Jan 2024RZ358 Treatment for Congenital Hyperinsulinism

Rezolute — PHASE3

TrialACTIVE NOT RECRUITING
May 2022HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)

Hanmi Pharmaceutical Company Limited — PHASE2

TrialRECRUITING
May 2019Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism

Zealand Pharma — PHASE3

TrialACTIVE NOT RECRUITING
Nov 201618FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism

Miguel Pampaloni — PHASE2

TrialRECRUITING
Oct 2013Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Cook Children's Health Care System — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Hyperinsulinemic hypoglycaemia.
Check the disease page for updates →

Clinical Trial Landscape

5 active trials
2Phase 3
2Phase 2
1Phase 1
5Total recruiting
Search clinical trials for Hyperinsulinemic hypoglycaemia

Recent News & Research

No recent news articles indexed yet for Hyperinsulinemic hypoglycaemia.
Search PubMed for Hyperinsulinemic hypoglycaemia

Browse all Hyperinsulinemic hypoglycaemia news →

Specialist Network

Top 6 by expertise

View all Hyperinsulinemic hypoglycaemia specialists →

Quick Actions